← All Sponsors
SPONSOR

Theresa Jacob, PhD, MPH

Total Trials
1
Recruiting
1
Phases
Phase 3

Theresa Jacob, PhD, MPH is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Severe Depression, Moderate Depression, Ketamine, Midazolam.

The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Theresa Jacob, PhD, MPH

How many clinical trials has Theresa Jacob, PhD, MPH sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Theresa Jacob, PhD, MPH, of which 1 are actively recruiting participants. These trials cover conditions including Severe Depression, Moderate Depression, Ketamine. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Theresa Jacob, PhD, MPH research focus on?
Theresa Jacob, PhD, MPH clinical trials span Severe Depression, Moderate Depression, Ketamine, Midazolam, Peripheral Nervous System Agents, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Theresa Jacob, PhD, MPH clinical trial?
To participate in a Theresa Jacob, PhD, MPH trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Theresa Jacob, PhD, MPH trials with current recruitment status updated daily.

Clinical Trials by Theresa Jacob, PhD, MPH

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology